ClinicalTrials.Veeva

Menu

The Etiology of New-onset Status Epilepticus

J

Jie Liu

Status

Completed

Conditions

Status Epilepticus

Treatments

Diagnostic Test: Perform autoimmune encephalitis titer tests

Study type

Observational

Funder types

Other

Identifiers

NCT05647525
Liujiessy

Details and patient eligibility

About

This study will help to identify the causes of new epilepsy and provide a basis for the development of a rational and standardized diagnosis and treatment plan to reduce the rate of disability and death.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of Status Epilepticus
  • Sign the informed consent form

Exclusion criteria

  • Patients with previous epilepsy
  • Missing information such as basic information and treatment history
  • Long-term smoking, alcohol and drug abuse
  • Pregnant and breastfeeding women

Trial design

60 participants in 1 patient group

status epilepticus with autoimmune encephalitis; status epilepticus without autoimmune encephalitis
Description:
To study the relationship between autoimmune-related antibody titres and prognosis during the six-month follow-up
Treatment:
Diagnostic Test: Perform autoimmune encephalitis titer tests

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems